stars 1 stars 2 stars 3

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases. Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability. Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation. At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.

Peel Therapeutics Questions

The Peel Therapeutics annual revenue was $2 million in 2026.

Joshua Schiffman is the CEO and Co-Founder of Peel Therapeutics.

7 people are employed at Peel Therapeutics.

Peel Therapeutics is based in Salt Lake City, Utah.

The NAICS codes for Peel Therapeutics are [541714, 54, 541, 5417, 54171].

The SIC codes for Peel Therapeutics are [873, 87].

Top Peel Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users